Inhibitors | Comment | Organism | Structure |
---|---|---|---|
NVP-231 | potent inhibition of ceramide kinase catalyzed production of ceramide 1-phosphate both in vitro and in cell-based assays | Mus musculus |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
ATP + ceramide | Mus musculus | - |
ADP + ceramide 1-phosphate | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Mus musculus | - |
- |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
dermal microvascular endothelial cell | - |
Mus musculus | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
ATP + ceramide | - |
Mus musculus | ADP + ceramide 1-phosphate | - |
? |
Synonyms | Comment | Organism |
---|---|---|
ceramide kinase | - |
Mus musculus |
CERK | - |
Mus musculus |
General Information | Comment | Organism |
---|---|---|
malfunction | capillary-like tube formation is significantly impaired in CerK-deficient cells or in wild type cells treated with NVP-231 as compared with untreated wild type cells, ceramide kinase ablation increases serum ceramide levels at the expense of dihydroceramide levels without affecting sphingosine, dihydrosphingosine, sphingosine-1-phosphate or dihydrosphingosine-1-phosphate levels, in both Cerk -/- and NVP-231-treated cells, the density of the cell monolayer area is in increased at the expense of the tube forming area | Mus musculus |
physiological function | ceramide kinase catalyzed formation of ceramide 1-phosphate may regulate angiogenesis by a novel mechanism that is independent of sphingosine-1-phosphate formation and signaling | Mus musculus |